rs144629123
Positions:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_130468.4(CHST14):āc.635T>Cā(p.Val212Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000322 in 1,613,726 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.00043 ( 1 hom., cov: 32)
Exomes š: 0.00031 ( 1 hom. )
Consequence
CHST14
NM_130468.4 missense
NM_130468.4 missense
Scores
3
13
3
Clinical Significance
Conservation
PhyloP100: 6.27
Genes affected
CHST14 (HGNC:24464): (carbohydrate sulfotransferase 14) This gene encodes a member of the HNK-1 family of sulfotransferases. The encoded protein transfers sulfate to the C-4 hydroxyl of N-acetylgalactosamine residues in dermatan sulfate. Mutations in this gene have been associated with adducted thumb-clubfoot syndrome.[provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.086407065).
BP6
Variant 15-40471848-T-C is Benign according to our data. Variant chr15-40471848-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 373593.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Benign=1, Uncertain_significance=2}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHST14 | NM_130468.4 | c.635T>C | p.Val212Ala | missense_variant | 1/1 | ENST00000306243.7 | NP_569735.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHST14 | ENST00000306243.7 | c.635T>C | p.Val212Ala | missense_variant | 1/1 | NM_130468.4 | ENSP00000307297 | P1 | ||
CHST14 | ENST00000559991.1 | c.560T>C | p.Val187Ala | missense_variant | 2/2 | 5 | ENSP00000453882 |
Frequencies
GnomAD3 genomes AF: 0.000427 AC: 65AN: 152142Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
65
AN:
152142
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000538 AC: 135AN: 251156Hom.: 2 AF XY: 0.000478 AC XY: 65AN XY: 135854
GnomAD3 exomes
AF:
AC:
135
AN:
251156
Hom.:
AF XY:
AC XY:
65
AN XY:
135854
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000311 AC: 455AN: 1461584Hom.: 1 Cov.: 32 AF XY: 0.000347 AC XY: 252AN XY: 727092
GnomAD4 exome
AF:
AC:
455
AN:
1461584
Hom.:
Cov.:
32
AF XY:
AC XY:
252
AN XY:
727092
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000427 AC: 65AN: 152142Hom.: 1 Cov.: 32 AF XY: 0.000350 AC XY: 26AN XY: 74332
GnomAD4 genome
AF:
AC:
65
AN:
152142
Hom.:
Cov.:
32
AF XY:
AC XY:
26
AN XY:
74332
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
14
ExAC
AF:
AC:
63
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 29, 2016 | A variant of uncertain significance has been identified in the CHST14 gene. The V212A variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The V212A substitution occurs at a position that is conserved through mammals, and alanine (A) is not wild type in any species. In addition, in silico analysis predicts this variant is probably damaging to the protein structure/function. Nonetheless, V212A is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. Finally, this variant has been reported in approximately 0.1-0.2% of alleles from individuals of European ancestry in the NHLBI Exome Sequencing Project and the Exome Aggregation Consortium (ExAC), including three homozygous individuals. - |
Ehlers-Danlos syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Mar 01, 2020 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | CHST14: PP3, BS2 - |
Ehlers-Danlos syndrome, musculocontractural type Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 11, 2024 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 09, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;.
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D
REVEL
Pathogenic
Sift
Uncertain
D;D
Sift4G
Uncertain
D;T
Polyphen
D;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at